Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cold Treatment Drug Market by Type (Cough Medicine, Respiratory Infections, Others, Cold Treatment Dru), By Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cold Treatment Drug Market by Type (Cough Medicine, Respiratory Infections, Others, Cold Treatment Dru), By Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168143 3300 Medical Devices & Consumables 377 238 Pages 4.5 (47)
                                          

The global cold treatment drug market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of respiratory infections and colds, rising awareness about the benefits of self-medication, and growing demand for over-the-counter drugs. The global cold treatment drug market is segmented on the basis of type into cough medicine, respiratory infections, and cold treatment drugs. The cough medicine segment accounted for the largest share in 2018 owing to its wide range of applications in treating coughs and other related symptoms such as sore throat or chest congestion. Respiratory infections are also gaining traction due to their ability to treat a variety of symptoms associated with common respiratory tract infection like fever, headache, muscle aches or fatigue among others. Cold treatment drugs are used for treating common symptoms associated with common cold like fever or headache among others. On the basis of application, the global cold treatment drug market can be divided into hospital pharmacy and retail pharmacy segments which accounted for significant shares in 2018 owing to their wide range of applications in treating various ailments including fever or headache among others at home without consulting a doctor first hand. Online pharmacies are also gaining traction due to their convenience factor which allows consumers access medicines without having any physical contact with them while still being able to get advice from doctors online through chatbots or video calls if needed.

  1. The global population is aging and the elderly are more susceptible to colds and flu.
  2. The rise in chronic diseases such as diabetes, obesity, and heart disease has led to an increase in the number of people with compromised immune systems who are more susceptible to colds and flu.
  3. There is a growing awareness of the importance of taking care of one's health by practicing good hygiene habits such as washing hands frequently, avoiding contact with sick people, getting enough sleep, eating healthy foods, exercising regularly etc, which can help prevent colds and flu from occurring or worsening if they do occur.
  4. There is a growing trend towards natural remedies for common ailments such as colds and flu.
  5. The increasing use of social media has led to an increased awareness about how best to take care of oneself during periods when there are high levels of viruses circulating.

Industry Growth Insights published a new data on “Cold Treatment Drug Market”. The research report is titled “Cold Treatment Drug Market research by Types (Cough Medicine, Respiratory Infections, Others, Cold Treatment Dru), By Applications (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Players/Companies Pfizer, Johnson & Johnson, VICKS, TEVA, Bayer, GSK, Novartis, Centrient Pharma, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, Sudafed, Merck, Reckitt Benckiser, TYLENOL, Cold Treatment Dru”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Cold Treatment Drug Market Research Report

By Type

Cough Medicine, Respiratory Infections, Others, Cold Treatment Dru

By Application

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

By Companies

Pfizer, Johnson & Johnson, VICKS, TEVA, Bayer, GSK, Novartis, Centrient Pharma, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, Sudafed, Merck, Reckitt Benckiser, TYLENOL, Cold Treatment Dru

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

238

Number of Tables & Figures

167

Customization Available

Yes, the report can be customized as per your need.


Global Cold Treatment Drug Industry Outlook


Global Cold Treatment Drug Market Report Segments:

The global Cold Treatment Drug market is segmented on the basis of:

Types

Cough Medicine, Respiratory Infections, Others, Cold Treatment Dru

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pfizer
  2. Johnson & Johnson
  3. VICKS
  4. TEVA
  5. Bayer
  6. GSK
  7. Novartis
  8. Centrient Pharma
  9. Mylan
  10. Cipla
  11. NCPC
  12. United Laboratories
  13. Sun Pharma
  14. CSPC
  15. LKPC
  16. Hikma
  17. Dr. Reddy
  18. HPGC
  19. Aurubindo
  20. Meiji Holdings
  21. Sudafed
  22. Merck
  23. Reckitt Benckiser
  24. TYLENOL
  25. Cold Treatment Dru

Global Cold Treatment Drug Market Overview


Highlights of The Cold Treatment Drug Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Cough Medicine
    2. Respiratory Infections
    3. Others
    4. Cold Treatment Dru
  1. By Application:

    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Online Pharmacy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cold Treatment Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cold Treatment Drug Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Cold treatment drug is a medication that is used to treat colds. It is a pill or liquid that you take by mouth. Cold treatment drugs work by reducing the number of colds you get and by helping to shorten the duration of your colds.

Some of the major players in the cold treatment drug market are Pfizer, Johnson & Johnson, VICKS, TEVA, Bayer, GSK, Novartis, Centrient Pharma, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, Sudafed, Merck, Reckitt Benckiser, TYLENOL, Cold Treatment Dru.

The cold treatment drug market is expected to register a CAGR of 4.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Cold Treatment Drug Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Cold Treatment Drug Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Cold Treatment Drug Market - Supply Chain
   4.5. Global Cold Treatment Drug Market Forecast
      4.5.1. Cold Treatment Drug Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Cold Treatment Drug Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Cold Treatment Drug Market Absolute $ Opportunity

5. Global Cold Treatment Drug Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Cold Treatment Drug Market Size and Volume Forecast by Type
      5.3.1. Cough Medicine
      5.3.2. Respiratory Infections
      5.3.3. Others
      5.3.4. Cold Treatment Dru
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Cold Treatment Drug Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Cold Treatment Drug Market Size and Volume Forecast by Application
      6.3.1. Hospital Pharmacy
      6.3.2. Retail Pharmacy
      6.3.3. Online Pharmacy
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Cold Treatment Drug Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Cold Treatment Drug Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Cold Treatment Drug Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Cold Treatment Drug Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Cold Treatment Drug Demand Share Forecast, 2019-2026

9. North America Cold Treatment Drug Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Cold Treatment Drug Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Cold Treatment Drug Market Size and Volume Forecast by Application
      9.4.1. Hospital Pharmacy
      9.4.2. Retail Pharmacy
      9.4.3. Online Pharmacy
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Cold Treatment Drug Market Size and Volume Forecast by Type
      9.7.1. Cough Medicine
      9.7.2. Respiratory Infections
      9.7.3. Others
      9.7.4. Cold Treatment Dru
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Cold Treatment Drug Demand Share Forecast, 2019-2026

10. Latin America Cold Treatment Drug Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Cold Treatment Drug Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Cold Treatment Drug Market Size and Volume Forecast by Application
      10.4.1. Hospital Pharmacy
      10.4.2. Retail Pharmacy
      10.4.3. Online Pharmacy
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Cold Treatment Drug Market Size and Volume Forecast by Type
      10.7.1. Cough Medicine
      10.7.2. Respiratory Infections
      10.7.3. Others
      10.7.4. Cold Treatment Dru
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Cold Treatment Drug Demand Share Forecast, 2019-2026

11. Europe Cold Treatment Drug Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Cold Treatment Drug Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Cold Treatment Drug Market Size and Volume Forecast by Application
      11.4.1. Hospital Pharmacy
      11.4.2. Retail Pharmacy
      11.4.3. Online Pharmacy
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Cold Treatment Drug Market Size and Volume Forecast by Type
      11.7.1. Cough Medicine
      11.7.2. Respiratory Infections
      11.7.3. Others
      11.7.4. Cold Treatment Dru
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Cold Treatment Drug Demand Share, 2019-2026

12. Asia Pacific Cold Treatment Drug Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Cold Treatment Drug Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Cold Treatment Drug Market Size and Volume Forecast by Application
      12.4.1. Hospital Pharmacy
      12.4.2. Retail Pharmacy
      12.4.3. Online Pharmacy
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Cold Treatment Drug Market Size and Volume Forecast by Type
      12.7.1. Cough Medicine
      12.7.2. Respiratory Infections
      12.7.3. Others
      12.7.4. Cold Treatment Dru
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Cold Treatment Drug Demand Share, 2019-2026

13. Middle East & Africa Cold Treatment Drug Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Cold Treatment Drug Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Cold Treatment Drug Market Size and Volume Forecast by Application
      13.4.1. Hospital Pharmacy
      13.4.2. Retail Pharmacy
      13.4.3. Online Pharmacy
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Cold Treatment Drug Market Size and Volume Forecast by Type
      13.7.1. Cough Medicine
      13.7.2. Respiratory Infections
      13.7.3. Others
      13.7.4. Cold Treatment Dru
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Cold Treatment Drug Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Cold Treatment Drug Market: Market Share Analysis
   14.2. Cold Treatment Drug Distributors and Customers
   14.3. Cold Treatment Drug Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pfizer
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Johnson & Johnson
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. VICKS
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. TEVA
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Bayer
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. GSK
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Novartis
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Centrient Pharma
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Mylan
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Cipla
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. NCPC
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. United Laboratories
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Sun Pharma
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. CSPC
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. LKPC
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Hikma
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Dr. Reddy
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. HPGC
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Aurubindo
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. Meiji Holdings
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us